3.95 USD
▼-0.12-2.95%
盘后 4.04 +2.17%
2026-11-19
市值
$1.24B
市盈率
—
EPS
-0.27
股息率
—
52 周区间
2.23 – 6.51
成交量
4.08M
Beta
1.09
目标价
8.33
52W 低 2.2352W 高 6.51
价格走势
公司简介
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. The company’s commercial products include Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes; Furoscix, a formulation of furosemide injection to treat edema in pediatric patients and adult...